Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

GLIPIZIDE AND METFORMIN HYDROCHLORIDE

GLIPIZIDE; METFORMIN HYDROCHLORIDE

Standard Dose
2.5MG;250MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview GLIPIZIDE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 078905 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GLIPIZIDE; METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 2.5MG;250MG Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2017-04-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview GLIPIZIDE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 078905 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GLIPIZIDE; METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 2.5MG;250MG Sponsor ZYDUS PHARMS USA INC Submission history Latest submission status date: 2017-04-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.